Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management

Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has improved cancer-related outcomes in the management of HR+ breast cancer, AIs are associated with musculoskeletal adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyder, Tara, Marino, Christopher C., Ahmad, Sasha, Nasrazadani, Azadeh, Brufsky, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353230/
https://www.ncbi.nlm.nih.gov/pubmed/34385978
http://dx.doi.org/10.3389/fendo.2021.713700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353230/
https://www.ncbi.nlm.nih.gov/pubmed/34385978
http://dx.doi.org/10.3389/fendo.2021.713700

Ejemplares similares